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Abstract Rare associations of immunological disorders
can often tell more than mice and rats about the
pathogenesis of immunologically mediated human kidney
disease. Cases of glomerular disease with thyroiditis and
Graves’ disease and of minimal change disease with
lymphoepithelioma-like thymic carcinoma and lymphoma-
toid papulosis were recently reported in Pediatric Nephrol-
ogy. These rare associations can contribute to the
unraveling of the pathogenesis of membranous nephropathy
(MN) and minimal change disease (MCD) and lead to the
testing of novel research hypotheses. In MN, the target
antigen may be thyroglobulin or another thyroid-released
antigen that becomes planted in the glomerulus, but other
scenarios can be envisaged, including epitope spreading,
polyreactivity of pathogenic antibodies, and dysregulation
of T regulatory cells, leading to the production of a variety
of auto-antibodies with different specificities [immune
dysregulation, polyendocrinopathy, enteropathy, X-linked
(IPEX syndrome)]. The occurrence of MCD with hemo-
pathies supports the role of T cells in the pathogenesis of
proteinuria, although the characteristics of those T cells







Membranous nephropathy (MN) and minimal change
disease (MCD) rank among the most frequent glomerular
diseases in adults and children, respectively. In the past
years, significant advances have been made in the under-
standing of their pathophysiology, although there are still
missing links.
Neutral endopeptidase, a zinc-dependent enzyme ex-
pressed on the surface of glomerular podocytes, has been
identified as the first antigen responsible for MN in a small
subset of patients with allo-immune antenatal glomerulop-
athy [1, 2]. The mothers became immunized against neutral
endopeptidase during pregnancy, because they were genet-
ically deficient in this enzyme. The maternal antibodies
were transferred to the fetus after the first trimester of
pregnancy and reached their target antigen in the fetus
glomeruli, where they induced a cascade of complement-
mediated events leading to severe injury. Although neutral
endopeptidase has not yet been found in immune deposits
of adult patients with MN, the description of this rare allo-
immune fetomaternal disease provided the proof of princi-
ple that podocyte antigens can serve as targets for in situ
formation of nephritogenic immune complexes in the
glomerular capillary wall. The next step will be to identify
those antigens.
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e-mail: pierre.ronco@tnn.aphp.frA possible link between abnormal T-cell response and
MCD was postulated more than 30 years ago [3]. Systemic
infusion of supernatants of T lymphocytes from patients
with MCD relapse induced proteinuria in rats [4]. Evidence
of T-cell implication has accumulated during the past
10 years. This includes an expansion of CD4+ and CD8+
T-cell populations, high nuclear factor kappa B (NFκB)
activation in CD4+ T cells [5], and upregulation in T cells
of RNA transcripts, which led to the identification of a new
gene, the c-maf-inducing protein (c-mip) gene [6]. The T-
cell anomalies occur during relapse and disappear during
remission. In addition, a role for CD34+ stem cells has also
been pointed out [7]. Cells expressing CD34 are normally
found in the umbilical cord and bone marrow as hemato-
poietic cells and endothelial progenitor cells. The data
suggest that the cells responsible for the pathogenesis of the
nephrotic syndrome are more likely to be immature
differentiating cells rather than mature peripheral T cells.
Although these findings point to a T cell lineage disorder,
the nature of the permeability factor(s) produced by T cells
or by T-cell activated ‘inflammatory’ cells remains elusive.
Rare associations of immunological disorders may
provide important clues to the pathogenesis of MN and
MCD. In the past 6 months, four reports of such
associations have appeared in Pediatric Nephrology. They
include two cases of membranoproliferative and membra-
nous glomerulonephritis (GN) associated with auto-immune
thyroiditis and Graves’ disease, respectively, [8, 9], and two
cases of MCD associated with lymphomatoid papulosis
[10] and lymphoepithelioma-like thymic carcinoma [11],
respectively. We will build on those case reports and
discuss how they can contribute to the understanding of
renal diseases and to the opening of new research avenues.
The case of membranous/membranoproliferative
glomerulonephritis and thyroiditis
Renal involvement in auto-immune thyroiditis is not
uncommon, occurring in 10% to 30% of cases. Although
several types of glomerulopathies, including MCD,
immunoglobulin A (IgA) nephropathy, rapidly progressive
GN and membranoproliferative glomerulonephritis
(MPGN), have been reported in patients with inflammatory
thyroiditis, MN is the most frequent [8, 12–14]. MN can
also occur in the course of Graves’ disease, where it may be
associated with, or induced by, administration of 131-iodine
(
131I) [15, 16]. The pathogenesis of glomerular disease and
the reason for the different patterns of glomerular injury in
this setting are not well understood. The association of
auto-immune thyroid disease with MN leads to discussion
of the pathogenesis of immune deposits occurring in the
glomerular capillary wall and to the proposal of new lines
of investigation of the mechanisms whereby the release of
thyroid antigens, particularly thyroglobulin and thyroper-
oxidase, may lead to an immune GN.
Are thyroglobulin-anti-thyroglobulin immune complexes
the culprits?
Auto-immune thyroiditis or thyroid gland irradiation can
induce the release in blood of thyroid antigens that trigger a
specific immune response and the formation of immune
complexes involving thyroid antigens [15, 17]. Thyroglob-
ulin and thyroperoxidase have been detected in subepithe-
lial immune deposits [9, 17], but there is no real proof that
these antigens and the corresponding antibodies are
pathogenic. Because of the increased permeability to
proteins of the glomerular capillary wall, they may have
been trapped passively in the glomerulus, as is the case for
albumin. Although the thyroglobulin–anti-thyroglobulin
immune complexes (or other immune complexes involving
thyroid antigens) can become deposited on the endothelial
side of the glomerular basement membrane, it is unlikely
that they can cross the basement membrane as a complex
and give rise to subepithelial immune deposits. Because
IgG4 is the main subclass deposited in MN [18], the
subclass of anti-thyroglobulin and anti-thyroperoxidase
antibodies should be determined in the patients with
thyroiditis-related GN. Indeed, IgG4 is characterized by
low affinity for the antigen, so that thyroglobulin/thyroper-
oxidase–IgG4 complexes may dissociate before crossing
the basement membrane and then re-associate on the
subepithelial side [19], although there is no experimental
evidence yet supporting this hypothesis. However, experi-
ments performed by the group of G. Andres favor the
concept of immune complex assembly and disassembly
[20]. Antibodies to angiotensin-converting enzyme
expressed on glomerular endothelial cells induce patching
of the antigen and shedding of the immune complexes at
the surface of endothelial cells, followed by the formation
of subepithelial immune deposits.
Perpetuation of auto-immune thyroiditis and production
of secondary renal lesions were induced by periodic injection
of aqueous preparations of altered thyroglobulin [21].
Although thyroglobulin antigen may become planted in the
glomerular capillary wall and, subsequently, serve as a target
for nephritogenic anti-thyroglobulin antibodies, other scenar-
ios can be envisaged, including epitope spreading, poly-
reactivity of pathogenic antibodies, and dysregulation of T
regulatory cells, leading to the production of a variety of
auto-antibodies with different specificities.
Intra- and inter-molecular epitope spreading
The primary immune responses against self-antigens such
as thyroglobulin tend to focus on one or few regions (called
4 Pediatr Nephrol (2009) 24:3–8epitopes) of those antigens, thus using a very limited
number of the available T-cell clones. This phenomenon is
called immunodominance. If the immunodominant re-
sponse fails to clear the target at first, the immune system
will mount a more diversified, and possibly long-lasting,
inflammatory response locally or systemically. This process
of broadening the initially restricted immune response is
called epitope spreading (Fig. 1). Spreading can occur
within a single molecule (intramolecular), i.e. thyroglobu-
lin, or among different molecules, possibly including
antigens that are expressed in the glomerulus. Then,
immune GN would be caused by a different subset of
auto-antibodies than those that are initially raised against
thyroglobulin or thyroperoxidase epitopes. It is believed
that the spreading process involves altered antigen process-
ing and presentation, as well as increased co-stimulation.
Epitope spreading has been demonstrated in experimen-
tal auto-immune thyroiditis [22], Heymann nephritis, a
reliable experimental model of MN [23], and in experi-
mental auto-immune GN induced in rats by a T-cell epitope
of Goodpasture’s antigen [24]. It has also been identified in
systemic lupus erythematosus, where triggering peptide
sequences have been characterized [25]. Epitope spreading
has been demonstrated during experimental immunization
with an immunogenic thyroglobulin peptide [26], but, to
our knowledge, it has not been investigated in patients with
auto-immune thyroiditis. Yet this phenomenon may be
relevant to pathogenesis of disease, since, in Heymann
nephritis, the onset of proteinuria correlates with intramo-
lecular epitope spreading [23].
Polyreactivity of pathogenic antibodies
Most studies of auto-antibody-mediated tissue damage have
focused on the role of anti-double-stranded DNA antibodies
in patients with lupus nephritis [27]. It has been proposed
that anti-double-stranded DNA, anti-nucleosome antibod-
ies, or both, cross-react with proteins in the kidney; thus,
they may have a direct pathogenic effect on renal cells. This
is an example of polyreactivity, whereby the same antibody
can bind to antigens with different structures because they
have similar surface shapes or areas of similar charges
(so-called shared epitopes or mimotopes) (Fig. 2). Among
possible target antigens in the kidney, attention is currently
focused on α-actinin. This protein that cross-links actin
(a component of the cytoskeleton) is critical for maintaining
the function of renal podocytes. Two studies have shown
that mouse monoclonal anti-DNA antibodies that cross-
reacted with α-actinin were pathogenic, whereas monoclo-
nal antibodies that did not cross-react with α-actinin were
not pathogenic [28, 29]. Anti-α-actinin antibodies are non-
specific for lupus. Whether anti-α-actinin antibodies can
cross-react with thyroglobulin or other thyroid antigens
remains to be established.
T-cell dysregulation and immune dysregulation,
polyendocrinopathy, enteropathy, X-linked syndrome
Immune dysregulation, polyendocrinopathy, enteropathy,
X-linked (IPEX) syndrome is a severe auto-immune
syndrome which highlights the importance of the reporting
of rare associations and their relevance to basic science.
Usually, the onset of the disease is in early infancy, and
the course is rapidly fatal. The enteropathy manifests itself
as a severe refractory and life-threatening diarrhea associ-
ated with villous atrophy. Other auto-immune manifesta-
tions include polyendocrinopathies such as type 1 diabetes,
Initiating epitope Intramolecular epitope spreading
Intermolecular epitope
spreading
Spreading of B cell epitopes
Fig. 1 B-cell epitope spreading. The primary immune response
against the dominant initiating epitope (shown in red) may further
extend to other epitopes within the same molecule (intramolecular
epitope spreading) or among different molecules (intermolecular
spreading). The initiating antigen is shown in blue. The secondary
antigen is shown in green
Polyreactive antibodies
Shared epitopes
Fig. 2 Polyreactivity of antibody. The same antibody can bind to
different molecules shown in blue and green, respectively, because
they have similar surface shapes or areas of similar charge. The
epitope is shown as a blue star. In polyreactive antibodies, the
antigen-binding pocket is more flexible
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usually with the presence of auto-antibodies. In addition,
eczema, typically correlated with elevated titers of IgE in
the serum, has also been reported. IPEX is caused by
mutations in the forkhead box protein P3 (FOXP3) gene
[30], which induce a dysfunction in CD4+ CD25
high T
regulatory (T reg) cells and in effector T cells [31]. This
rare entity thus shows that multiple auto-immune manifes-
tations, including hypothyroidism, can be caused by T reg
defects.
Very interestingly, the first case of kidney involvement in
IPEX syndrome was described in the early 1990s by Renée
Habib’sg r o u p[ 32], who reported a case of MN associated
with severe auto-immune enteropathy (AIE) with anti-
enterocyte antibodies, anti-tubular basement membrane anti-
bodies, and anti-brush-border antibodies. Target antigens
include proteins with molecular weight (MW) of 75 kDa,
58 kDa and 55 kDa, with the anti-AIE-75 antibodies being
specific for auto-immune enteropathies with renal involve-
ment [33]. Whether the antigen is also expressed on the
podocyte surface remains to be established.
IPEX is an example of T-cell dysregulation associated
with MN. The disease is rare, but retrospective data suggest
that its actual frequency may be underestimated. The
association of MN with unusual auto-immune manifesta-
tions in male patients must trigger investigations in the
patient’s family and lead to the consideration of T-cell
dysregulation and FOXP3 mutations as a potential cause of
the disease. We suggest that IPEX and related syndromes
may be the cause of childhood MN with anti-tubular
basement membrane and/or anti-brush-border antibodies.
The case of nephrotic syndrome (minimal change disease)
and hemopathies
Because MCD is considered to be a consequence of
immune cell dysfunction that may lead to release of a
glomerular permeability factor, particular attention has been
paid to the association of MCD with hemopathies,
particularly those of lymphoid origin or involving lymphoid
cells. The best example of MCD associated with hemop-
athy is Hodgkin’s lymphoma (HL). Although this associa-
tion is rare, representing only 0.4% of cases in the two
largest studies of 1,700 Hodgkin’s disease patients, a close
relationship between the courses of HL and MCD has been
reported in patients who suffer from both diseases;
particularly, remission of MCD occurs after successful
treatment of HL, suggesting that MCD is a paraneoplastic
syndrome in the context of HL [34]. Hodgkin Reed–
Sternberg cells seem to derive from germinal center B cells,
and molecular studies suggest that, in rare cases, they may
derive from T cells [35]. However, in a recent retrospective
French study of 21 cases [36], Audard et al. failed to
demonstrate expression of T-cell markers. Nonetheless, in
agreement with the hypothesis of T-cell impairment, many
similarities concerning T-cell function during MCD and
Hodgkin’s lymphoma have been documented [36]. Both
diseases are associated with an expansion of T cells
polarized towards a Th2 phenotype with Th2 cytokines,
particularly interleukin-13 (IL-13), being involved; consis-
tent NFκ-B overexpression in Reed–Sternberg cells and in
peripheral mononuclear cells including T cells during MCD
relapse has been documented. The fact that MCD-related
nephrotic syndrome disappears when lymphoma is cured
strongly supports the existence of a permeability factor
which may be secreted by the Hodgkin’s cells or by the
surrounding inflammatory cells.
Recently, two reports in Pediatric Nephrology on the
association of MCD with lymphoepithelioma-like thymic
carcinoma [11] and lymphomatoid papulosis [10] further
support the concept of a permeability factor secreted by
T cells. Lymphomatoid papulosis of the skin is considered
to be a CD30+ cutaneous lymphoma of uncertain malig-
nant potential. The patient presented a series of remissions
and relapses synchronous with the nephrotic syndrome. The
etiology of the disease is unknown, but it is relevant that
lymphomatoid papulosis can be concomitant with, or
followed by, other lymphomas, such as mycosis fungoides
and Hodgkin’s lymphoma. This raises the question of a
common origin of the diseases, because, in some cases, the
same neoplastic T-cell clone has been identified in lesions
of lymphomatoid papulosis and in the other developed
malignancy [37].
The largest series of patients with renal involvement
associated with thymic pathology was published by Karras
et al. [38]. The case reported by Kiliś-Pstrusińska et al. [11]
is the first one of MCD associated with lymphoepithelioma-
like thymic carcinoma in a pediatric patient. Thymomas
have been associated with different auto-immune diseases
[38] most likely due to the induction of auto-reactive T-cell
clones. As in the diseases mentioned above, the dysregu-
lation of T-cell activity and/or increased production of
several lymphokines by activated T lymphocytes may alter
renal glomerular permeability.
These rare associations may provide useful cell tools and
sera to further investigate the pathophysiology of MCD,
which remains largely elusive. First, the screening of genes
upregulatedintheTcellsofpatientswithMCDrelapsehasled
to the identification of c-mip in the Tcells [5]. Analysis of c-
mip expression in Hodgkin’s Reed–Sternberg cells, in
abnormal thymic cells, and in lymphomatoid papulosis cells,
would be of great interest. One important question that
remains to be solved relates to the peculiar characteristics of
Hodgkin’s cells associated with MCD: c-mip expression in
those cells might help identify patients with Hodgkin’s
lymphoma and a risk for MCD. In addition, the finding of
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develop MCD would further support a role for c-mip in the
pathophysiology of MCD. Second, immortalization of the
involved lymphoma cells could provide valuable material for
isolation of glomerular permeability factor(s).
In conclusion, much has been learned in the past few
years from the careful analysis of single observations of
well-phenotyped patients. However, the editorial policy of a
number of medical journals tends to exclude isolated
reports of single cases. For lack of time due to a dramatic
shortage or reduction in the number of nephrologists in
many countries [39, 40], and because of the epidemics of
chronic kidney disease, little attention is being paid to
unusual presentations of clinical cases or to rare associa-
tions of diseases. This is a threat to future progress in
medicine. Rare human cases can tell more than extensive
studies in mice and rats.
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